New aspects of the treatment of alopecia areata

Postepy Dermatologii i Alergologii

Volumn 31, Issue 4, 2014, Pages 262-265

  Brzezińska Wcisło, Ligia ^a   Bergler Czop, Beata ^a   Wcisło Dziadecka, Dominika ^a   Lis ͆wiety, Anna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Alopecia areata; Treatment

Indexed keywords

AZATHIOPRINE; BOTULINUM TOXIN; CLOBETASOL; CYCLOSPORIN; CYCLOSPORIN A; GLUCOCORTICOID; LIOTHYRONINE; METHOTREXATE; METHYLPREDNISOLONE; PIMECROLIMUS; SALAZOSULFAPYRIDINE; TRIAMCINOLONE ACETONIDE;

ALOPECIA AREATA; AUTOIMMUNE DISEASE; CHILDHOOD DISEASE; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERANCE; EMOTION; HAIR FOLLICLE; HAIR LOSS; HEALTH STATUS; HELICOBACTER INFECTION; HUMAN; NERVOUS SYSTEM FUNCTION; PSYCHOTRAUMA; QUALITY OF LIFE; RECURRENCE RISK; REMISSION; REVIEW; UREA BREATH TEST;

EID: 84907022227     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2014.40923     Document Type: Review

References (26)

1. Brzezińska-Wcisło L, Lis-͆wie{ogonek}ty A. Hair diseases - what's new? In: Dermatology - what's new? [Polish]. Vol. 1. Szepietowski J, Reich A (eds.). Cornetis, Wrocław 2009; 187-200.
2. Burgdorf WHC, Plewig G, Wolff HH, Landthaler M. Hair diseases. In: Braun-Falco Dermatology [Polish]. Vol. 2. Czelej, Lublin 2010; 1053-83.
3. Brzezińska-Wcisło L, Lis A, Kamińska G, Wcisło-Dziadecka D. Physiology and pathology of hair growth and loss on the human scalp [Polish]. Postep Derm Alergol 2003; 20: 260-6.
4. Brzezińska-Wcisło L, Wcisło-Dziadecka D, Meszyńska E, et al. New perspectives on the pathogenesis and treatment of hair disorders. Post Nauk Med 2012; 10: 800-5.
5. Łuczak M, Łuczak T, Cies̈cińska C, Czajkowski R. General treatment of alopecia areata [Polish]. Przegl Dermatol 2013; 100: 53-8.
6. Acikgöz G, Ozmen I, Cayirli M, et al. Pulse methylprednisolone therapy for the treatment of extensive alopecia areata. J Dermatolog Treat 2014; 25: 164-6.
7. Staumont-Sallé D, Vonarx M, Lengrand F, et al. Pulse corticosteroid therapy for alopecia areata: log-term outcome after 10. Dermatology 2012; 225: 81-7.
8. Bin Saif GA, Al-Khawajah MM, Al-Otaibi HM, et al. Efficacy and safety of oral mega pulse methylprednisolone for severe therapy resistant Alopecia areata. Sudi Med J 2012; 33: 284-91.
9. Alsantali A. Alopecia areata: a new treatment plan. Clin Cosmet Investig Dermatol 2011; 4: 107-15.
10. Farshi S, Mansouri P, Safar F, Khiabanloo SR. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study. Int J Dermatol 2010; 49: 1188-93.
11. Droitcourt C, Milpied B, Ezzedine K, et al. Interest of highdose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: a retrospective case series. Dermatology 2012; 224: 369-73.
12. Miteva M, Tosti A. Treatment options for alopecia: an update looking to the future. Expert Opin Pharmocter 2012; 13: 1271-81.
13. Bhat YJ, Manzoor S, Khan AR, Qayooni S. Trace element levels in alopecia areata. Indian J Dermatol Venereol Leprol 2009; 75: 29-31.
14. Ito T, Aoshima M, Ito N, et al. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata. Arch Dermatol Res 2009; 301: 373-80.
15. Cho HR, Lew BL, Lew H, Sim WY. Treatment effects of intradermal botulinum toxin type A injection on alopecia areata. Dermatol Surg 2010; 4: 2175-81.
16. Abedini H, Farshi S, Mirabzadeh A, Keshavarz S. Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder. J Dermatolog Treat 2014; 25: 153-5.
17. Otberg N. Systemic treatment for alopecia areata. Dermatol Ther 2011; 24: 320-5.
18. Luk NM, Chiu LS, Lee KC, et al. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata. J Eur Acad Dermatol Venereol 2013; 27: e400-5.
19. Campuzano-Maya G. Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol 2011; 17: 3165-70.
20. Bayramgürler D, Demirsoy EO, Aktürk AS, Kiran R. Narrowband ultraviolet B phototherapy for alopecia areata. Photodermatol Photoimmunol Photomed 2011; 27: 325-7.
21. Raijiv M, Singh N. Bexarotene gel: a new topical therapy for alopecia areata. Int J Trichology 2010; 2: 66-7.
22. Ucak H, Kandi B, Cicek D, et al. The comparison of treatment with clobetasol propionate 0,05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata. J Dermatolog Treat 2012; 23: 410-20.
23. Nasiri S, Haghpanah V, Taheri E, et al. Hair regrowth, with topical triiodothyronine ointment in patients with alopecia areata: a double-blind, randomized pilot clinical trial of efficacy. Eur Acad Dermatol Venereol 2012; 26: 654-6.
24. Manolache L, Petrescu-Seceleanu D, Benea V. Alopecia areata and relationship with stressful events in children. J Eur Acad Dermatol Venereol 2009; 23: 107-9.
25. Willemsen R, Vanderlinden J, Roseeuw D, Haentjens P. Increased history of childhood and lifetime traumatic events among adults with alopecia areata. J Eur Acad Dermatol Venereol 2009; 60: 388-93.
26. MacDonald Hull SP, Wood ML, Hutchinson PE, et al. British Association of Dermatologists. Guidelines for the management of alopecia areata. Br J Dermatol 2003; 149: 692-9.